Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer’s Disease

Cerebrovascular diseases such as ischemic stroke are known to exacerbate dementia caused by neurodegenerative pathologies such as Alzheimer’s disease (AD). Besides, the increasing number of patients surviving stroke makes it necessary to treat the co-occurrence of these two diseases with a single an...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso, José M., Escobar-Peso, Alejandro, Palomino-Antolín, Alejandra, Diez-Iriepa, Daniel, Chioua, Mourad, Martínez-Alonso, Emma, Iriepa, Isabel, Egea, Javier, Alcázar, Alberto, Marco-Contelles, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465398/
https://www.ncbi.nlm.nih.gov/pubmed/34577561
http://dx.doi.org/10.3390/ph14090861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465398/
https://www.ncbi.nlm.nih.gov/pubmed/34577561
http://dx.doi.org/10.3390/ph14090861

Ejemplares similares